Financials data is unavailable for this security.
Cash flow in USDView more
In 2024, Tiziana Life Sciences Ltd increased its cash reserves by 214.79%, or 2.54m. Cash Flow from Financing totalled 4.51m or -- of revenues. In addition the company used 1.53m for operations while cash used for investing totalled 71.00k.
| Cash flow per share | -0.1117 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 0.0774 |
|---|---|
| Tangible book value per share | 0.0774 |
More ▼
Balance sheet in USDView more
| Current ratio | 1.72 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.0116 |
|---|---|
| Total debt/total capital | 0.0115 |
More ▼
